<--- Back to Details
First PageDocument Content
Breakthrough therapy / Chemistry / Pharmaceutical sciences / Carbamates / Pharmacology / Pyrrolidines / Ombitasvir/paritaprevir/ritonavir / Ritonavir / Ombitasvir / AbbVie Inc. / Paritaprevir / Kidney
Date: 2016-08-04 23:27:20
Breakthrough therapy
Chemistry
Pharmaceutical sciences
Carbamates
Pharmacology
Pyrrolidines
Ombitasvir/paritaprevir/ritonavir
Ritonavir
Ombitasvir
AbbVie Inc.
Paritaprevir
Kidney

Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of inconsistency between the Japanese original and this English translatio

Add to Reading List

Source URL: www.pmda.go.jp

Download Document from Source Website

File Size: 95,95 KB

Share Document on Facebook

Similar Documents

Chemistry_BS_Biochemistry.pdf

Chemistry_BS_Biochemistry.pdf

DocID: 1xUCR - View Document

Chemistry_BS_Environmental Chemistry.pdf

Chemistry_BS_Environmental Chemistry.pdf

DocID: 1xUxX - View Document

Chemistry, BA

Chemistry, BA "DBEFNJD.BQ  General

DocID: 1xU5A - View Document

The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with

The Next Bigly Thing -- Torsion Chemistry 80% Faster Reactions, 50% Less Energy with "Activators" by Robert A. Nelson Science has bestowed many wonderments upon us, but the Return-On-Investment is quickly diminishing (th

DocID: 1xTUH - View Document

Chemistry_BS_General BS to MS Accelerated Pathway.pdf

Chemistry_BS_General BS to MS Accelerated Pathway.pdf

DocID: 1xTpY - View Document